Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma

Keyphrases

• Kaposi Sarcoma 100%
• Pegylated Liposomal Doxorubicin 100%
• Western Countries 50%
• Nanoparticles 25%
• Africa 25%
• Treatment Choice 25%
• Delivery System 25%
• Antiretroviral Therapy 25%
• Cytotoxic Chemotherapy 25%
• Doxorubicin 25%
• Clinical Evidence 25%
• Interferon-α (IFN-α) 25%
• Chemotherapy Alone 25%
• Viscera 25%
• Western World 25%
• Sub-Saharan African Countries 25%
• Vascular Tumor 25%
• Enhanced Efficacy 25%
• Reduced Toxicity 25%
• Cytotoxic Agents 25%
• Efficacy-toxicity 25%
• Tumor Localization 25%
• PEGylated Liposomes 25%
• Liposome Delivery 25%
• HIV-related Kaposi's Sarcoma 25%
• HIV Pandemic 25%
• Alitretinoin 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Doxorubicin 100%
• Acquired Immune Deficiency Syndrome 100%
• Kaposi Sarcoma 100%
• HIV 40%
• Cytotoxic Chemotherapy 20%
• Chemotherapy Regimens 20%
• Nanoparticle 20%
• Alpha Interferon 20%
• Liposome 20%
• Vascular Tumor 20%
• Neoplasm 20%
• Alitretinoin 20%
• Diseases 20%
• Cytotoxic Agent 20%